房颤患者症状与生活质量变化及其对预后的影响
研究前瞻性随访3836例已知房颤患者平均3.7年,每年收集房颤相关症状和生活质量(QoL)信息。主要终点为卒中或系统性栓塞复合终点。结果显示房颤相关症状与主要终点及所有次要终点均无显著关联,而QoL与心衰住院、心血管死亡和全因死亡显著相关。
要点
- 房颤相关症状与卒中/系统性栓塞等不良结局无显著关联,不应作为预后治疗决策依据。
- QoL每提高5分,心衰住院、心血管死亡和全因死亡风险显著降低。
- 症状患者更年轻、阵发性房颤比例更高、QoL更低,但症状本身不预测预后。
核心结论
- 房颤相关症状与不良结局无关,不应作为预后治疗决策的基础。
- 生活质量与充血性心衰住院、心血管死亡和全因死亡强烈相关。
研究设计与样本
- 前瞻性随访3836例已知房颤患者,平均随访3.7年。
- 每年收集房颤相关症状和生活质量信息。
- 主要终点为卒中或系统性栓塞复合终点。
- 采用多变量、时间更新Cox比例风险模型评估关联。
主要发现
- 平均年龄72岁,72%为男性。
- 有房颤相关症状者占66%,较无症状者更年轻(70 vs 74岁,p<0.0001),阵发性房颤比例更高(56% vs 37%,p<0.0001),QoL更低(71 vs 72分,p=0.009)。
- 主要终点发生率在有症状和无症状患者中分别为1.05和1.02/100人年。
- 房颤相关症状对主要终点的多变量校正HR(95%CI)为1.11(0.77至1.59;p=0.56),与所有次要终点均无关联。
- QoL每增加5分,主要终点aHR为0.98(0.94至1.03;p=0.37),心衰住院aHR为0.92(0.90至0.94;p<0.0001),心血管死亡aHR为0.90(0.86至0.95;p<0.0001),全因死亡aHR为0.88(0.86至0.90;p<0.0001)。
临床怎么用
- 房颤相关症状不应作为预后治疗决策的依据。
- 应关注房颤患者的生活质量,其与心衰住院、心血管死亡和全因死亡密切相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to investigate changes in atrial fibrillation (AF)-related symptoms and quality of life (QoL) over time, and their impact on prognosis. METHODS: We prospectively followed 3836 patients with known AF for a mean of 3.7 years. Information on AF-related symptoms and QoL was obtained yearly. The primary end point was a composite of stroke or systemic embolism. Main secondary end points included stroke subtypes, all-cause mortality, cardiovascular death, hospitalisation for congestive heart failure (CHF), myocardial infarction and major bleeding. We assessed associations using multivariable, time-updated Cox proportional hazards models. RESULTS: Mean age was 72 years, 72% were male. Patients with AF-related symptoms (66%) were younger (70 vs 74 years, p<0.0001), more often had paroxysmal AF (56% vs 37%, p<0.0001) and had lower QoL (71 vs 72 points, p=0.009). The incidence of the primary end point was 1.05 and 1.02 per 100 person-years in patients with and without symptoms, respectively. The multivariable adjusted HR (aHR) (95% CIs) for the primary end point was 1.11 (0.77 to 1.59; p=0.56) for AF-related symptoms. AF-related symptoms were not associated with any of the secondary end points. QoL was not significantly related to the primary end point (aHR per 5-point increase 0.98 (0.94 to 1.03; p=0.37)), but was significantly related to CHF hospitalisations (0.92 (0.90 to 0.94; p<0.0001)), cardiovascular death (0.90 (0.86 to 0.95; p<0.0001)) and all-cause mortality (0.88 (0.86 to 0.90; p<0.0001)). CONCLUSIONS: AF-related symptoms were not associated with adverse outcomes and should therefore not be the basis for prognostic treatment decisions. QoL was strongly associated with CHF, cardiovascular death and all-cause mortality.
引用
- Krisai P, Blum S, Aeschbacher S, et al. Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation. Heart. 2020. PMID: 32234819. doi:10.1136/heartjnl-2019-316314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。